` Biotech in SA

` BioSA Mandate/About BioSA

` History and partnership with COFISA
` Activities implemented
` The Road Ahead
` Acknowledgements

-2-
OECD single definition

The application of science and technology to living

organisms, as well as parts, products and models
thereof, to alter living or non-living materials for the
production of knowledge, goods and services

-3-
` “It is really difficult to turn a research
dollar into a profit dollar”

` “At the risk of stating the obvious-

biology is difficult”

-4-
Red: health care Green: plant biotechnology
z Medicines z Agricultural
z Biomaterials applications
z Functional food z Food

Grey: White:
environmental industrial
applications biotechnology
z Bioproduction
(biorefinery)
z Bioproducts
z Bioenergy
z Enzymes in products
and as biocatalysts
100%
Risk Maximum Return
Potential

Value
50%

Cost

0%
Technical Product Safety / Clinicals /
Conception Commercialize
Feasibility Development Prototype tests Manufacturing

Univ. Biotech SMME’s

-6-
Big Industry Players
 Tertiary Education Institutes - •41% of national core
Science Councils - companies
•40% of national research
Private Companies (Core) - groups

•37% of national core

companies
•34% of national research
groups

DST eGoliBio Biotech Survey 2003

Criteria 2003 Survey 2007 Survey

Core Biotech Co’s 47 38

Co’s more than 50 staff 4 4

Non-Core Co’s (Biotech active) 59 78

Employment 627 765

Revenue R368 million R520 million

-8-
-9-
` Biotech in SA
` BioSA Mandate/About BioSA
` History and partnership with COFISA
` Activities implemented
` The Road Ahead
` Acknowledgements

- 10 -
• Founded in Sep 2007
• Bio2Biz meeting in Cape Town
• Independent voice for private biotech
SMMEs
• Network of committed biotech
entrepreneurs
• Membership of mostly biotech SMEs

- 11 -
 Objectives
` support and represent the interests of private
biotech SMMEs in the biotechnology and life
sciences industries in South Africa
` offer membership to all organisations and/or
individuals sharing its objectives
` foster awareness in industry, government,
educational institutions and other bodies in South
Africa on the application and potential of
biotechnology and life sciences based on
scientific facts

- 12 -
 Objectives
` to be a source of information for the public about
private biotech SMMEs in the biotechnology and
life sciences industries in South Africa and their
activities, as well as to encourage full and open
public debate on biotechnology and its
implications
` liaise and co-operate, when considered
appropriate, with organisations with similar
objectives in the attainment of the objectives of
the Association

- 13 -
 Objectives
` provide a forum for the exchange of information
and policy debate amongst private SMMEs in the
biotech and life sciences sectors and Association
members.

- 14 -
` Interaction amongst members (learn from each
other)
` Interaction with international players (learn from
international best practice)
` Work with Government for change
` Invest in skills development
` Attract FDI

- 15 -
` BioSA Mandate
` History and partnership with COFISA
` Activities implemented
` The Road Ahead
` Acknowledgements

- 16 -
 COFISA Æ 2009 2009-2018

New frameworks and tools

ls for RIS development
too
&
o rks
m ew ight
fr a es
y fo r Intermediary mechanisms
lic ial
-Po in c
Parks for triple-helix collaboration
ov i e n c e
-Pr -Sc
ramme
P r o g
-CoE
-Cluster development
2007 -Business initiatives New innovation capacities
-Wir in the business sector
e
-Liv less Vi
ing llag
la b e
dev
elop
men
t Open innovation platforms
for rural ICT

- 17 -

17
` Finnish Embassy Workshop
` Trade exchange visit with Finnish regional biotech
leaders
` IPR Act Workshop
` BioSA sustainability plan

` Foresighting exercises
` Bioprospecting events
` Innovation leadership program

- 18 -
` Learn about the biotech sector and the players
throughout the country
` Develop regional contact points for dissemination
of information
` Identify the strengths of the different regions in
contributing toward growth in the biotech and life
sciences sector
` Network with a Finnish delegation to inform them
of the regional stregths to encourage FDI

- 19 -
` Biomaterials and Tissue Engineering
` Telemedicine
` Genomics
` Bioprospecting: Plant diversity, identify, analyse
and characterise molecules
` Extremophiles
` Biodiversity in Coral Reefs
` Molecular medicine
` Infectious disease diagnostics: HIV/TB/Malaria

- 20 -
` BioSA Mandate
` History and partnership with COFISA
` Activities implemented
` The Road Ahead
` Acknowledgements

- 21 -
` Database of SMMEs in South Africa
` BioSA web site as a first contact point for
interested parties
` Market SMMEs on the website

- 22 -
• Representation at the TIA Bill hearings
• Biotech skills survey
• Bioprospecting Seminar
• Biotech Cluster in Gauteng
• IPR Act Workshop

- 23 -
` BioSA Mandate
` History and partnership with COFISA
` Activities implemented
` The Road Ahead
` Acknowledgements

- 24 -
- 25 -
- 26 -
 YEAR 1

BioSA

Executive Director

Admin
Assistant/Marketing

- 27 -
 Chair- Biotech
Lobbyist

Non-Exec Non-Exec
Executive Non-Exec Non-Exec Non-Exec International
Fund Legal
Director Financial Member Member Funder
Raising Oversight

- 28 -
 Shareholder

SS01 Represent and SSO2 Deliver value

promote the adding support
interests of private services and
structures for
biotech SMMEs biotech SMMEs

CSO1 CSO2 CSO3 Host a forum for

Customer

Market the exchange of

Grow SMME portfolios of information and
membership SMME opportunities
members amongst members

SPO1
Internal
Process

Satisfy funding
requirements for
financial sustainability
Organizational

ODSO2
Development

Establish Strategic
Alliances with
other biotech
organisations

- 29 -
` COFISA: Nirvash Seetal, Thoko Mandyu
` Facilitators: Stephan Lamprechts
` Service Providers
` BioSA Management Team

- 30 -